Molecular Pathways in the Development of HPV-induced Cervical Cancer

Overview

Journal EXCLI J

Specialty Biology

Date 2021 Mar 22

PMID 33746665

Citations 19

Authors

Farnaz Rasi Bonab

Amir Baghbanzadeh

Moslem Ghaseminia

Nadia Bolandi

Ahad Mokhtarzadeh

Mohammad Amini

Kianoosh Dadashzadeh

Khalil Hajiasgharzadeh

Behzad Baradaran

Hossein Bannazadeh Baghi

Affiliations

Soon will be listed here.

Abstract

Recently, human papillomavirus (HPV) has gained considerable attention in cervical cancer research studies. It is one of the most important sexually transmitted diseases that can affect 160 to 289 out of 10000 persons every year. Due to the infectious nature of this virus, HPV can be considered a serious threat. The knowledge of viral structure, especially for viral oncoproteins like E6, E7, and their role in causing cancer is very important. This virus has different paths (PI3K/Akt, Wnt/β-catenin, ERK/MAPK, and JAK/STAT) that are involved in the transmission of signaling paths through active molecules like MEK (pMEK), ERK (pERK), and Akt (pAkt). It's eventually through these paths that cancer is developed. Precise knowledge of these paths and their signals give us the prognosis to adopt appropriate goals for prevention and control of these series of cancer.

Citing Articles

Role of CK7 Immunoreactivity in Predicting Progression of the Cervical Intraepithelial Neoplasia: A Retrospective Cross-sectional Study.

Sarmadi S, Nili F, Anousha K Iran J Pathol. 2025; 19(4):384-391.

PMID: 40034924 PMC: 11872037. DOI: 10.30699/IJP.2024.2019662.3239.

Computational analysis of Ayurvedic herbs to explore their potential role as anti-cervical cancer agents.

Dange S, Aggarwal N, Verma R, Sinha Y, Dadhiya S, Mittal G Mol Biol Res Commun. 2025; 14(2):129-141.

PMID: 40028476 PMC: 11865937. DOI: 10.22099/mbrc.2024.51173.2038.

RPL22L1 fosters malignant features of cervical cancer via the modulation of DUSP6-ERK axis.

Zhang D, Zhao M, Jiang P, Zhou Y, Yan X, Zhou C J Transl Med. 2025; 23(1):244.

PMID: 40022129 PMC: 11871735. DOI: 10.1186/s12967-025-06249-0.

MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring.

Kepsha M, Timofeeva A, Chernyshev V, Silachev D, Mezhevitinova E, Sukhikh G Int J Mol Sci. 2025; 25(24.

PMID: 39769036 PMC: 11678179. DOI: 10.3390/ijms252413271.

Prevalence of high-risk human papillomavirus genotypes and viral load correlated with squamous cell inflammation among women in Gabon.

Mombo-Maganga C, Mangala C, Mabika-Obanda A, Maulot-Bangola D, Ambounda-Ledaga N, Matsomo-Kombet G BMC Womens Health. 2024; 24(1):561.

PMID: 39396007 PMC: 11475162. DOI: 10.1186/s12905-024-03403-6.

References

Jones D, Thompson D, Munger K . Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology. 1998; 239(1):97-107. DOI: 10.1006/viro.1997.8851. View

Ammermann I, Bruckner M, Matthes F, Iftner T, Stubenrauch F . Inhibition of transcription and DNA replication by the papillomavirus E8-E2C protein is mediated by interaction with corepressor molecules. J Virol. 2008; 82(11):5127-36. PMC: 2395219. DOI: 10.1128/JVI.02647-07. View

OShea J, Gadina M, Schreiber R . Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 2002; 109 Suppl:S121-31. DOI: 10.1016/s0092-8674(02)00701-8. View

Bleul C, Fuhlbrigge R, Casasnovas J, Aiuti A, Springer T . A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996; 184(3):1101-9. PMC: 2192798. DOI: 10.1084/jem.184.3.1101. View

Patel D, Huang S, Baglia L, McCance D . The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 1999; 18(18):5061-72. PMC: 1171577. DOI: 10.1093/emboj/18.18.5061. View

DeMasi J, Huh K, Nakatani Y, Munger K, Howley P . Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding. Proc Natl Acad Sci U S A. 2005; 102(32):11486-91. PMC: 1182553. DOI: 10.1073/pnas.0505322102. View

Yousefi B, Darabi M, Baradaran B, Shekari Khaniani M, Rahbani M, Darabi M . Inhibition of MEK/ERK1/2 Signaling Affects the Fatty Acid Composition of HepG2 Human Hepatic Cell Line. Bioimpacts. 2013; 2(3):145-50. PMC: 3648933. DOI: 10.5681/bi.2012.019. View

Herr P, Basler K . Porcupine-mediated lipidation is required for Wnt recognition by Wls. Dev Biol. 2011; 361(2):392-402. DOI: 10.1016/j.ydbio.2011.11.003. View

Bossler F, Kuhn B, Gunther T, Kraemer S, Khalkar P, Adrian S . Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling. mBio. 2019; 10(1). PMC: 6372795. DOI: 10.1128/mBio.02323-18. View

10.

Blodt S, Holmberg C, Muller-Nordhorn J, Rieckmann N . Human Papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18-25 year old male and female vocational school students in Berlin, Germany. Eur J Public Health. 2011; 22(6):808-13. DOI: 10.1093/eurpub/ckr188. View

11.

Thomas M, Banks L . Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene. 1999; 17(23):2943-54. DOI: 10.1038/sj.onc.1202223. View

12.

Lessard J, Robinson R, Hoffman H . Differential expression of ras signal transduction mediators in verrucous and squamous cell carcinomas of the upper aerodigestive tract. Arch Pathol Lab Med. 2001; 125(9):1200-3. DOI: 10.5858/2001-125-1200-DEORST. View

13.

Bushmeyer S, Park K, Atchison M . Characterization of functional domains within the multifunctional transcription factor, YY1. J Biol Chem. 1995; 270(50):30213-20. DOI: 10.1074/jbc.270.50.30213. View

14.

Pim D, Storey A, Thomas M, Massimi P, Banks L . Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Oncogene. 1994; 9(7):1869-76. View

15.

Maksym R, Tarnowski M, Grymula K, Tarnowska J, Wysoczynski M, Liu R . The role of stromal-derived factor-1--CXCR7 axis in development and cancer. Eur J Pharmacol. 2009; 625(1-3):31-40. PMC: 2783873. DOI: 10.1016/j.ejphar.2009.04.071. View

16.

Kruiswijk F, Labuschagne C, Vousden K . p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol. 2015; 16(7):393-405. DOI: 10.1038/nrm4007. View

17.

Gazon H, Barbeau B, Mesnard J, Peloponese Jr J . Hijacking of the AP-1 Signaling Pathway during Development of ATL. Front Microbiol. 2018; 8:2686. PMC: 5775265. DOI: 10.3389/fmicb.2017.02686. View

18.

DuShane J, Maginnis M . Human DNA Virus Exploitation of the MAPK-ERK Cascade. Int J Mol Sci. 2019; 20(14). PMC: 6679023. DOI: 10.3390/ijms20143427. View

19.

Shen G, Jeong W, Hu R, Kong A . Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents. Antioxid Redox Signal. 2005; 7(11-12):1648-63. DOI: 10.1089/ars.2005.7.1648. View

20.

Lichy J, Majidi M, Elbaum J, Tsai M . Differential expression of the human ST5 gene in HeLa-fibroblast hybrid cell lines mediated by YY1: evidence that YY1 plays a part in tumor suppression. Nucleic Acids Res. 1996; 24(23):4700-8. PMC: 146314. DOI: 10.1093/nar/24.23.4700. View